Pipotiazine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Headbomb (talk | contribs) at 00:38, 28 June 2016 (clean up, replaced: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... \et al.] → Brazilian Journal of Medical and using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Pipotiazine
Clinical data
Trade namesPiportil
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral, IM
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • 10-[3-[4-(2-hydroxyethyl)-1-piperidyl]propyl]-N,N-dimethyl-phenothiazine-2-sulfonamide
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.049.672 Edit this at Wikidata
Chemical and physical data
FormulaC24H33N3O3S2
Molar mass475.67 g/mol g·mol−1
3D model (JSmol)
  • CN(C)S(=O)(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCC(CC4)CCO

Pipotiazine (Piportil), also known as pipothiazine, is a typical antipsychotic of the phenothiazine class[1] used in the United Kingdom and other countries for the treatment of schizophrenia.[2] Its properties are similar to those of chlorpromazine.

See also

References

  1. ^ Bechelli, L. P.; Ruffino-Netto, A.; Hetem, G. (1983). "A double-blind controlled trial of pipotiazine, haloperidol and placebo in recently-hospitalized acute schizophrenic patients". Brazilian Journal of Medical and Biological Research. 16 (4): 305–311. PMID 6143579.
  2. ^ International Drug Names